A SOLIHULL woman, battling multiple sclerosis, has slammed a local decision to ban a drug used to treat the condition.
Heather Wilson, a retired HSBC worker, suffers from progressive MS and is furious that she’s unable to access Sativex simply because she lives in the Midlands.
The 68-year-old, spent three years on the ‘Cupid trial’ – giving her access to a cannabis-based drug that is similar to the Sativex.
“The other drug was so successful, I was out of pain and I was able to sleep. I could do away with the other three drugs I take,” she said.
Heather, who needs to have her drugs prescribed by a neurologist, says the new rule means she cannot access Sativex unless she buys it from a website in Scotland – at £500 a time.
“We are going back to the postcode lottery,” she said, “I would just like to try the Sativex.
“I go to bed at night and instead of being able to relax, I am very stiff in my body.
“With the ‘Cupid trial’ I was able to go to bed and sleep for eight hours straight.”
Jayne Spink, from the MS Society, said: “This decision beggars belief. Sativex has undergone extensive clinical testing over many years.
“It’s a national disgrace that people with MS in the UK are already amongst the least likely in Europe to have access to MS drugs.”
The Midland Therapeutics Review & Advisory Committee took the decision to ban the drug last month, becoming the first in the country to do so.
A report by the organisation argues that there’s “inadequate” evidence about the drug’s effectiveness and safety.
However the drug is available elsewhere in the UK.